Clinical Trial Update: A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether glutamine can prevent oxaliplatin-induced neurotoxicity has been withdrawn; the update also includes a pharmacokinetic analys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Glutamine (glutamine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Colorectal Carcinoma, Neoplasms, Colorectal | Phase 2 | Status: WITHDRAWN